Results

Total Results: 2,231 records

Showing results for "medication".
Users also searched for: medication reconciliation

2221. Final Research Plan: Unhealthy Drug Use: Screening | United States Preventive Services Taskforce
      www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/drug-use-illicit-screening
      October 20, 2016 - dependent drug use are out of scope for this review; therefore, pharmacotherapy interventions (including medication-assisted

2222. Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
      www.uspreventiveservicestaskforce.org/home/getfilebytoken/5W2k4HLBPLPgHov6sSvuMH
      July 24, 2018 - Services Task Force (USPSTF) has main- tained an “A” recommendation for prophylactic ocular topical medication

2223. Screening for Osteoporosis: An Update for the U.S. Preventive Services Task Force (pdf file)
      www.uspreventiveservicestaskforce.org/home/getfilebytoken/RPB3rmcS9CK_eXPdzXSxZg
      July 01, 2010 - risk-assessment instruments; and sys­ tematic reviews and population-based studies of bone measure­ ment tests or medication … Fracture Outcomes of Placebo-Controlled Primary Prevention Trials, by Type of Fracture* Medication … Case reports of severe musculoskeletal pain that may be reversible after discontinuing the medication … of evidence Consistent Primary prevention trials are Poor to bisphosphonates, 1 trial of varies by medication … Adverse Health Outcomes from Studies, by Medication Adverse Outcome Evidence Bisphosphonates Withdrawals

2224. Bleeding Risks With Aspirin Use for Primary Prevention in Adults: A Systematic Review for the USPSTF (pdf file)
      www.uspreventiveservicestaskforce.org/home/getfilebytoken/j69Hq5ALvzg74e-ngkzSep
      April 01, 2016 - co- morbidities (diabetes, liver disease, ulcer disease, and previous GI bleeding), and concurrent medication … A patient's willingness and ability to use a daily medication is another consideration for selecting … m2): 1.24 (1.13–1.35) 0.85 (0.71–1.02) Previous GI hospitalization (yes vs. no) – – 2.87 (2.46–3.35) Medication … Participants, n Mean Age (Range), y Women, % Diabetes, % Current Smokers, % Aspirin Dose and Frequency Co-medication

2225. Screening for Preeclampsia US Preventive Services Task Force (pdf file)
      www.uspreventiveservicestaskforce.org/home/getfilebytoken/Y5p8ZXy2ydg_VZMUfxbJ-6
      April 25, 2017 - Approaches to Prevention The USPSTF recommends the use of low-dose aspirin (81 mg/d) as preventive medication … The USPSTF recommends the use of low-dose aspirin (81 mg/d) as preventive medication after 12 weeks of

2226. John B. Wong, M.D. | United States Preventive Services Taskforce
      www.uspreventiveservicestaskforce.org/uspstf/node/133
      March 01, 2018 - John B. Wong, M.D. Member John B. Wong, M.D., is chief scientific officer, vice chair for Clinical Affairs, chief of the Division of Clinical Decision Making, and a primary care clinician in the Department of Medicine at Tufts Medical Center. He is also director of comparative effectiveness research for th…

2227. John B. Wong, M.D. | United States Preventive Services Taskforce
      www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/current-members/john-b-wong-md
      March 01, 2018 - John B. Wong, M.D. Member John B. Wong, M.D., is interim chief scientific officer, vice chair for Academic Affairs, chief of the Division of Clinical Decision Making, and a primary care clinician in the Department of Medicine at Tufts Medical Center. He is also director of comparative effectiveness researc…

2228. John B. Wong, M.D. | United States Preventive Services Taskforce
      www.uspreventiveservicestaskforce.org/uspstf/john-b-wong-md
      March 01, 2018 - Share to Facebook Share to X Share to WhatsApp Share to Email Print John B. Wong, M.D. Member John B. Wong, M.D., is vice chair for Academic Affairs, chief of the Division of Clinical Decision Making, and a primary care clinician in the Depar…

2229. U.S. Preventive Services Task Force Issues Final Recommendation Statement on Medications for Risk Reduction of Primary Breast Cancer in Women (pdf file)
      www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/breastcanmedsbulletin.pdf
      September 24, 2013 - U.S. Preventive Services Task Force Issues Final Recommendation Statement on Medications for Risk Reduction of Primary Breast Cancer in Women U.S. Preventive Services Task Force Issues Final Recommendation Statement on Medications for Risk Reduction of Primary Breast Cancer in Women WASHINGTON, D.C. – Sept. 24, …

2230. U.S. Preventive Services Task Force Issues Draft Recommendation Statement on Interventions for Tobacco Cessation in Adults (pdf file)
      www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/tobacco-cessation-adults-draft-rec-bulletin.pdf
      June 29, 2020 - U.S. Preventive Services Task Force Issues Draft Recommendation Statement on Interventions for Tobacco Cessation in Adults www.uspreventiveservicestaskforce.org U.S. Preventive Services Task Force Issues Draft Recommendation Statement on Interventions for Tobacco Cessation in Adults Task Force recommends clin…

2231. U.S. Preventive Services Task Force Issues Final Recommendation Statement on Interventions for Tobacco Cessation in Adults (pdf file)
      www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/tobacco-cessation-adults-final-rec-bulletin.pdf
      January 19, 2021 - U.S. Preventive Services Task Force Issues Final Recommendation Statement on Interventions for Tobacco Cessation in Adults www.uspreventiveservicestaskforce.org U.S. Preventive Services Task Force Issues Final Recommendation Statement on Interventions for Tobacco Cessation in Adults Task Force recommends clin…